Effect of IV Dexamethasone on the Outcome of Acute Hemorrhagic Stroke
DOI:
https://doi.org/10.70749/ijbr.v3i7.2031Keywords:
Hemorrhagic Dexamethasone, stroke, Mortality, Steroids, Randomized controlled trialAbstract
Background: There is high morbidity and mortality with acute hemorrhagic stroke. The treatment is essentially supportive, and whether outcomes can be improved with the use of corticosteroids is still debatable. Considering the ability of dexamethasone in attenuating cerebral edema as well as inflammatory response, its effect on short-term mortality needs exploration. Objective: To compare the outcome (30-day mortality) between steroids (IV dexamethasone) and placebo in patients with acute hemorrhagic stroke. Study Design: Randomized controlled trial. Duration and Place of Study: This study was conducted from February to May 2025 in the Department of Medicine, Combined Military Hospital, Rawalakot. Methodology: A total of 106 patients aged 16–75 years with CT-confirmed acute hemorrhagic stroke were randomly assigned to two groups (n=53 each) using a lottery method. The treatment group received a structured 10-day course of IV dexamethasone; the control group received visually identical placebo. Demographic and clinical variables including age, gender, BMI, smoking, hypertension, diabetes, and hyperlipidemia were recorded. The primary outcome was all-cause mortality at 30 days. Results: Overall 30-day mortality was lower in the dexamethasone group (26.4%) compared to placebo (43.4%), though not statistically significant (p=0.067). Significant mortality reductions with dexamethasone were noted in subgroups including females (p=0.020), patients over 45 years (p=0.031), BMI >25 (p=0.019), hypertensives (p=0.037), diabetics (p=0.023), smokers (p=0.034), and those with hyperlipidemia (p=0.016). Conclusion: Intravenous dexamethasone may reduce 30-day mortality in acute hemorrhagic stroke, particularly in high-risk subgroups.
Downloads
References
1. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064-2089.
https://doi.org/10.1161/STR.0b013e318296aeca.
2. Bautista W, Adelson PD, Bicher N, Themistocleous M, Tsivgoulis G, Chang JJ. Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage. Ther Adv Neurol Disord. 2021;14:17562864211049208.
https://doi.org/10.1177/17562864211049208.
3. Richmond J, Quarles J, Talati S, Pandey J. Educational case: mechanism and locations of intracranial hypertensive hemorrhage leading to stroke. Acad Pathol. 2025;12(1):100165.
https://doi.org/10.1016/j.acpath.2025.100165.
4. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Mild Traumatic Brain Injury; Valente JH, Anderson JD, Paolo WF, Sarmiento K, Tomaszewski CA, et al. Clinical policy: critical issues in the management of adult patients presenting to the emergency department with mild traumatic brain injury. Ann Emerg Med. 2023;81(5):e63-e105.
https://doi.org/10.1016/j.annemergmed.2023.01.014.
5. Strilciuc S, Grad DA, Radu C, Chira D, Stan A, Ungureanu M, et al. The economic burden of stroke: a systematic review of cost of illness studies. J Med Life. 2021;14(5):606-619.
https://doi.org/10.25122/jml-2021-0361.
6. Ahmed Z, Chaudhary F, Agrawal DK. Epidemiology, pathophysiology, and current treatment strategies in stroke. Cardiol Cardiovasc Med. 2024;8(4):389-404.
https://doi.org/10.26502/fccm.92920399.
7. Bonanno FG. Management of hemorrhagic shock: physiology approach, timing and strategies. J Clin Med. 2022;12(1):260.
https://doi.org/10.3390/jcm12010260.
8. Svedung Wettervik T, Corell A, Sunila M, Enblad P, Velle F, Lindvall P, et al. Decompressive craniectomy in aneurysmal subarachnoid hemorrhage: can favorable outcome be achieved? Acta Neurochir (Wien). 2025;167(1):68.
https://doi.org/10.1007/s00701-025-06485-9.
9. Kareemi H, Pratte M, English S, Hendin A. Initial diagnosis and management of acutely elevated intracranial pressure. J Intensive Care Med. 2023;38(7):643-650.
https://doi.org/10.1177/08850666231156589.
10. Magid-Bernstein J, Girard R, Polster S, Srinath A, Romanos S, Awad IA, et al. Cerebral hemorrhage: pathophysiology, treatment, and future directions. Circ Res. 2022;130(8):1204-1229.
https://doi.org/10.1161/CIRCRESAHA.121.319949.
11. Yao Y, Liu F, Gu Z, Wang J, Xu L, Yu Y, et al. Emerging diagnostic markers and therapeutic targets in post-stroke hemorrhagic transformation and brain edema. Front Mol Neurosci. 2023;16:1286351.
https://doi.org/10.3389/fnmol.2023.1286351.
12. Ye Y, Xu J, Han Y. Dexamethasone for delayed edema after intracerebral hemorrhage: to be or not to be? Heliyon. 2023;9(7):e17621.
https://doi.org/10.1016/j.heliyon.2023.e17621.
13. Cook AM, Morgan Jones G, Hawryluk GWJ, Mailloux P, McLaughlin D, Papangelou A, et al. Guidelines for the acute treatment of cerebral edema in neurocritical care patients. Neurocrit Care. 2020;32(3):647-666.
https://doi.org/10.1007/s12028-020-00959-7.
14. Jaffa MN, Podell JE, Foroutan A, Motta M, Chang WW, Cherian J, et al. Steroids provide temporary improvement of refractory pain following subarachnoid hemorrhage. Neurohospitalist. 2023;13(3):236-242.
https://doi.org/10.1177/19418744231172350.
15. Zaganas I, Halpin AP, Oleink A, Kotzamani D, Chlapoutaki C, Tsimoulis D, et al. A comparison of acute hemorrhagic stroke outcomes in two populations: the Crete-Boston study. Stroke. 2010;41(4):212-215.
https://doi.org/10.1161/strokeaha.111.632174
16. Ogun SA, Odusote KA. Effectiveness of high dose dexamethasone in the treatment of acute stroke. West Afr J Med. 2001;20(1):1-6.
https://doi.org/10.4314/ajns.v20i1.7523
17. Sharafadinzadeh N, Baghebanian SM, Pipelzadeh M, Moravej-Ale A, Ghanavati P. Effects of dexamethasone in primary intracerebral hemorrhage in the south west of Iran. Pak J Med Sci. 2008;24(4):502-505.
18. Al-Amin MA, Mumin A, Kabir AKMS, Noor RA, Rahman MA, Rahman U, et al. Role of dexamethasone in the management of acute ischaemic stroke in a tertiary hospital: a randomized clinical study. Dinkum J Med Innov. 2024;3(2):118-131.
https://doi.org/10.71017/djmi.3.2.d-0245.
19. Wang Y, Huang L, Li J, Duan J, Pan X, Menon BK, et al. Efficacy and safety of corticosteroids for stroke and traumatic brain injury: a systematic review and meta-analysis. Syst Rev. 2025;14(1):54.
https://doi.org/10.1186/s13643-025-02803-5.
20. Zaganas I, Halpin AP, Oleinik A, et al. A comparison of acute hemorrhagic stroke outcomes in two populations: the Crete-Boston study. Stroke. 2011;42(12):3640-3642.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
